Published in Biotech Law Weekly, November 19th, 2004
The new Pharmacor study entitled "Community-Acquired Pneumonia" lists Pfizer's Zithromax, Abbott's Biaxin/Klacid, Roche's Rocephin, and Johnson & Johnson's Levaquin as major antibiotics that will face generic competition.
The study also finds that drug sales in the highly saturated, increasingly competitive market...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.